Collins, Bipartisan Group Introduce Bill to Spur Development of New Drugs to Treat Rare Childhood Diseases
August 12, 2024
August 12, 2024
WASHINGTON, Aug. 12 -- Sen. Susan M. Collins, R-Maine, issued the following news release:
Senator Susan Collins joined Senators Bob Casey (D-PA), Markwayne Mullin (R-OK), and Sherrod Brown (D-OH) in introducing the Creating Hope Reauthorization Act to encourage the development of drugs to treat rare diseases affecting children. The bipartisan legislation would extend the Food and Drug Administration's (FDA) Rare Pediatric Disease Priority Review Voucher (PRV) program, which incentiv . . .
Senator Susan Collins joined Senators Bob Casey (D-PA), Markwayne Mullin (R-OK), and Sherrod Brown (D-OH) in introducing the Creating Hope Reauthorization Act to encourage the development of drugs to treat rare diseases affecting children. The bipartisan legislation would extend the Food and Drug Administration's (FDA) Rare Pediatric Disease Priority Review Voucher (PRV) program, which incentiv . . .